With the right strategies, you can ‘treat the treatment’ and use your MS medications reliably and successfully.

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

The Global Multiple Sclerosis Drugs Market achieved a valuation of $23.2 Billion in 2024 and is anticipated to exceed $53.25 ...

Sarah Reed, an MS patient, will join some 5,000 other cyclists in riding in the Texas MS 150 this weekend, a 150-mile ride to ...

Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...

Learn how a ketogenic diet can help relieve multiple sclerosis symptoms including fatigue brain fog and loss of mobility and ...

Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

Drilling down into subgroups of patients, Sanofi also claimed that amlitelimab demonstrated “compelling efficacy” in patients ...

Potential New Drug Treatment for Multiple Sclerosis Dec. 8, 2023 — Pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis ...

SALES FORECAST: The group's sales should come to 15.33 billion Swiss francs ($18.94 billion), according to consensus estimates of 14 analysts compiled by Visible Alpha. This compares with 14.39 ...